Oral Ribavirin for the Treatment of Respiratory Syncytial Virus Infection in Allogeneic Stem Cell Transplant Recipients-Utility of the Immunodeficiency Scoring Index for Risk Stratification
Year: 2015
Type: article
Abstract: Respiratory syncytial virus (RSV) infection is a serious complication post allogeneic stem cell transplant. Aerosolized ribavirin is a commonly used therapy; however, oral ribavirin is an alternative with many advantages. There is paucity in literature regarding treatment outcomes using the oral form. Recently, the immunodeficiency scoring index (ISI) was derived from the largest reported RSV cohort to date using aerosolized ribavirin.
Institutions: Mayo Clinic, University of Iowa
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2130942470